Safety profile of MenB-FHBp vaccine among adolescents: data from surveillance of Adverse Events Following Immunization in Puglia (Italy), 2018-2020

• Автори: Pasquale Stefanizzi (Автор), Francesco Paolo Bianchi (Автор), Andrea Martinelli (Автор), Antonio Di Lorenzo (Автор), Paola De Petro (Автор), Giusi Graziano (Автор), Sabrina Lattanzio (Автор), Giusy Diella (Автор), Paolo Stella (Автор), Domenica Ancona (Автор), Silvio Tafuri (Автор)
• Формат: Книга
• Опубліковано: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

MenB-FHBp was licensed in Europe in 2017 from the age of 10. In the "postmarketing life" of a new vaccine, surveillance of Adverse Events Following Immunization (AEFI) is crucial, to better understand the pattern of safety and the effectiveness. This paper describes the MenB-FHBp AEFIs not...